Photodynamic therapy for pancreatic cancer

Pancreas

Volumn 34, Issue 4, 2007, Pages 385-389

  Fan, Bo Guang ^a   Andrén Sandberg, Åke ^b  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Necrosis; Pancreatic cancer; Photodynamic therapy; Photosensitizer

Indexed keywords

PHOTOSENSITIZING AGENT;

ALLERGY; CANCER CELL DESTRUCTION; CANCER GROWTH; CANCER SURVIVAL; HUMAN; LIGHT; MEDICAL RESEARCH; MEDLINE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TISSUE NECROSIS;

EID: 34248167056     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/mpa.0b013e3180439c50     Document Type: Review

References (63)

1. Kern S, Hruban R, Hollingsworth MA, et al. A white paper: the production of a pancreas cancer think tank. Cancer Res. 2001;61:4923-4932.
2. Takamori H, Hiraoka T, Kanemitsu K, et al. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer - under-analysis of cumulative survival curve. World J Surg. 2006;30:213-218.
3. Baumel H, Huguier M, Manderscheid JC, et al. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg. 1994;81:102-107.
4. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indications. J Gastrointest Surg. 2000;4:567-579.
5. Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg. 2003;27:324-329.
6. Dalton RR, Sarr MG, van Heerden JA, et al. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992;111:489-494.
7. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg. 1996;223:506-512.
8. Bown SG, Rogowska AZ, Whitelaw DE, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50:549-557.
9. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
10. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85:443-456.
11. Daniell MD, Hill JS. A history of photodynamic therapy. Aust NZ J Surg. 1991;61:340-348.
12. Bonnett R. Photodynamic therapy in historical perspective. Rev Contemp Pharmacother. 1999;10:1-17.
13. Wilson BC. Photodynamic therapy for cancer principles. Can J Gastroenterol. 2002;16:393-396.
14. Bown SG, Lovat LB. The biology of photodynamic therapy in the gastrointestinal tract. Gastrointest Endosc Clin N Am. 2000;10:533-550.
15. Wang N, Liu Y, Xie MX, et al. Changes in plasma membrane protein structure after photodynamic action in freshly isolated rat pancreatic acini. An FTIR study. J Photochem Photobiol B. 2003;71:27-34.
16. Salet C, Moreno G. Photosensitization of mitochondria. Molecular and cellular aspects. J Photochem Photobiol B. 1990;5:133-150.
17. Evensen JF, Malik Z, Moan J. Ultrastructural changes in the nuclei of human carcinoma cells after photodynamic treatment haematoporphyrin derivative and with tetrasodiummeso-tetra-(4-sulphonatophenyl) porphine. Lasers Med Sci. 1988;3:195-206.
18. Nelson JS, Liaw LH, Bern MW. Tumour destruction in photodynamic therapy. Photochem Photobiol. 1987;46:829-835.
19. Henderson BW, Donovan JM. Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res. 1989;49:6896-6900.
20. Fingar VH, Wieman TJ, Doak KW. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res. 1990;50:2599-2603.
21. Evans S, Matthews W, Perry R, et al. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl Cancer Inst. 1990;82:34-49.
22. Korbelik M. Induction of tumour immunity by photodynamic therapy. J Clin Laser Med Surg. 1996;14:329-334.
23. Moesta KT, Schlag P, Douglass HO Jr, et al. Evaluating the role of photodynamic therapy in the management of pancreatic cancer. Lasers Surg Med. 1995;16:84-92.
24. Sheng C, Pogue BW, Wang E, et al. Assessment of photosensitizer dosimetry and tissue damage assay for photodynamic therapy in advanced-stage tumors. Photochem Photobiol. 2004;79(6):520-525.
25. Laftavi MRA, Lens P, Margonari J, et al. Photodynamic therapy can selectively eradicate pancreas exocrine secretion. Transplant Proc. 1998;30:596-598.
26. Hopper MC. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 2000;1(4):212-219.
27. Chan HH, Nishioka NS, Mino M, et al. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointest Endosc. 2004;59:95-99.
28. Dima VF, Vasiliu V, Dima SV. Photodynamic therapy: an update. Roum Arch Microbiol Immunol. 1998;57:207-230.
29. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci. 1997;12:182-199.
30. Robinson DJ, de Bruijn HS, van der Veen N, et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol. 1998;67:140-149.
31. Boere IA, Robinson DJ, de Bruijn HS, et al. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol. 2003;78:271-277.
32. Hasan TACE, Moor B, Ortel B, et al. Photodynamic therapy of cancer. In: Kute D, Pollock R, Weichselbaum R, eds. Holland-Frei Cancer Medicine. Hamilton, Ontario, Canada: Dekker Inc.; 2003:605-622.
33. Witjes MJ, Mank AJ, Speelman OC, et al. Distribution of aluminum phthalocyanine disulfonate in an oral squamous cell carcinoma model. In vivo fluorescence imaging compared with ex vivo analytical models. Photochem Photobiol. 1997;65:685-693.
34. Selvasekar CR, Birbeck N, Mcmillana T, et al. Review article: photodynamic therapy and the alimentary tract. Aliment Pharmacol Ther. 2001;15:899-915.
35. Gordon TA, Cameron JL. Management of patients with carcinoma of the pancreas. J Am Coll Surg. 1995;181:558-560.
36. Gudjonson B. Carcinoma of the pancreas: critical analysis of costs, results of resection and the need for standardized reporting. J Am Coll Surg. 1995;181:483-503.
37. Mang TS, Wieman TJ. Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics. Photochem Photobiol. 1987;46:853-858.
38. Schroder T, Chen IW, Sperling M, et al. Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma. J Surg Oncol. 1988;38:4-9.
39. Chatlani PT, Nuutinen PJ, Toda N, et al. Selective necrosis in hamster pancreatic tumours using photodynamic therapy with phthalocyanine photosensitization. Br J Surg. 1992;79:786-790.
40. Regula J, Ravi B, Bedwell J, et al. Photodynamic therapy using 5-aminolevulinic acid for experimental pancreatic cancer prolonged animal survival. Br J Cancer. 1994;70:248-254.
41. Evrard S, Keller P, Hajri A, et al. Experimental pancreas cancer in the rat treated by photodynamic therapy. Br J Surg. 1994;81:1185-1189.
42. Mlkvy P, Messmann H, Pauer M, et al. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer. 1996;73:1473-1479.
43. Mlkvy P, Messmann H, MacRobert AJ, et al. Photodynamic therapy of transplanted pancreatic cancer model using metatetrahydroxyphenylchlorin (mTHPC). Br J Cancer. 1997;76:713-718.
44. Hajri A, Coffy S, Vallat F, et al. Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo. Br J Surg. 1999;86:899-906.
45. Gross S, Gilead A, Scherz A, et al. Monitoring photodynamic therapy of solid tumours online by BOLD-contrast MRI. Nat Med. 2003;9:1327-1331.
46. Nuutinen PJ, Chatlani PT, Bedwell J, et al. Distribution and photodynamic effect of disulphonated aluminium phthalocyanine in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer. 1991;64:1108-1115.
47. Hubmer A, Herman A, Uberriegler K, et al. Roles of calcium in photodynamically-induced cell damage of human fibroblasts. Photochem Photobiol. 1996;64:211-215.
48. Matthews EK, Cui ZJ. Photodynamic action of sulphonated aluminium phthalocyanine (SALPC) on AR4-2J cells, a carcinoma cell line of rat exocrine pancreas. Br J Cancer. 1990;61:695-701.
49. al-Laith M, Matthews EK. Calcium-dependent photodynamic action of di- and tetrasulphonated aluminium phthalocyanine on normal and tumour-derived rat pancreatic exocrine cells. Br J Cancer. 1994;70:893-899.
50. Liu CD, Kwan D, Saxton RE. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res. 2000;93:137-143.
51. Lipson RL, Blades EJ, Gray MJ. Hematoporphyrin derivative for the detection and management of cancer. Cancer. 1967;20:2255-2257.
52. Canto MI. Staining in gastrointestinal endoscopy. Basics Endosc. 1999;31:479-486.
53. Andersson-Engels S, Klinteberg C, Svanberg K, et al. In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol. 1997;42:815-824.
54. Sibata CH, Colussi VC, Oleinick NL, et al. Photodynamic therapy in oncology. Expert Opin Pharmacother. 2001;2:917-927.
55. McCaughan JS. Photodynamic therapy: a review. Drugs Aging. 1999;15:49-68.
56. Abulafi AM, Allardice JT, Williams NS, et al. Photodynamic therapy for malignant tumours of the ampulla of Vater. Gut. 1995;36:853-856.
57. Tseng WW, Saxton RE, Deganutti A, et al. Infrared laser activation of indocyanine green inhibits growth in human pancreatic cancer. Pancreas. 2003;27(3):42-45.
58. Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat. 2005;4(3):283-293.
59. Pass HI, DeLaney TF, Tochner Z, et al. Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol. 1994;1:28-37.
60. Baas P, Murrer L, Zoetmulder FAN, et al. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer. 1997;76:819-826.
61. Takita H, Dougherty TJ. Intracavity photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol. 1995;11:368-371.
62. Ris HB, Altermatt HJ, Nachbur B, et al. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med. 1996;18:39-45.
63. Triesscheijn M, Paul Baas P, Schellens LHM, et al. Photodynamic therapy in oncology. Oncologist. 2006;11:1034-1044.